← Field Notes
Diagnostics · 10 min read

What bloodwork actually matters in your 40s

ApoB, ferritin, hormones, inflammation, glucose, and the markers worth knowing before you chase advanced testing.

Bloodwork in your 40s is one of the highest-leverage routine investments you can make in your own health — and one of the easiest to get wrong. The mistake is rarely 'not enough tests.' It is testing without context, interpreting in isolation, or chasing advanced panels before the standard ones have been understood.

Why bloodwork gets confusing

Lab values are reference-range artifacts. 'Normal' on a lab report means 'within the distribution of the population sampled' — not 'optimal for you.' Two people with identical numbers can have very different clinical pictures depending on age, family history, medications, lifestyle, and trajectory over time.

The work that matters is interpretation, ideally with a clinician who knows your context.

Start with cardiometabolic basics

A standard panel — lipids, fasting glucose, HbA1c, blood pressure, kidney and liver function, complete blood count — is usually the right starting point. These are the inputs most likely to inform real decisions about cardiovascular and metabolic risk in your 40s.

ApoB and Lp(a): why they come up in risk conversations

Current US primary-prevention guidance treats certain markers as risk-enhancing factors in a broader cardiovascular risk discussion. ApoB reflects the number of atherogenic particles, and Lp(a) is a largely genetically determined risk marker that most people only need measured once in their adult life. Both are reasonable to discuss with a clinician — not as standalone verdicts, but as inputs to the larger conversation.

Glucose and insulin context

Fasting glucose and HbA1c are the standard glycemic snapshots. They are useful, and they are limited — a 'normal' HbA1c does not preclude meaningful postprandial glucose excursions, and an isolated reading does not establish a diagnosis. Trend, context, and behavior matter more than any one number.

Ferritin, thyroid, hormones, and inflammation

Iron status (including ferritin), thyroid function, sex hormones, and inflammatory markers can be meaningful when there is a clinical reason to look — fatigue, cycle changes, mood, training adaptation, recovery, recurring illness. Testing without a question can produce numbers you then feel pressured to act on.

When more testing creates more noise

Advanced panels, micronutrient screens, and broad hormone arrays can produce dozens of flagged values, very few of which are actionable in isolation. If a result will not change a decision, or cannot be interpreted by a clinician you trust, the highest-resolution test is not necessarily the most useful one.

Questions to ask your clinician

A simple frame for the conversation:

  • Given my history and risk profile, what should we be measuring this year?
  • Are there markers, like ApoB and Lp(a), that you want to include in our cardiovascular risk discussion?
  • How will we use these results to decide next steps?
  • When will we repeat any of this — and what would trigger an earlier recheck?
What this means
  • Bloodwork is most valuable when it sits inside a clinical relationship and a clear question.
  • The standard panels, well-interpreted, beat advanced panels poorly interpreted.
What to be careful about
  • Treating reference ranges as personal targets.
  • Acting on isolated values without trend or context.
  • Self-prescribing supplements or interventions based on a single lab.
Questions to ask
  • What decision would this test inform?
  • Who will interpret the result with me?
  • Is this the right time to measure, or am I chasing a number?
Sources & further reading

This Field Note is for educational purposes only and is not medical advice, diagnosis, treatment recommendation, or individualized health guidance. Always consult a qualified healthcare professional before making health decisions.

Explore the Atlas

Bring a sharper map to the next decision.

Compare credible tools, diagnostics, clinics, programs, and education across the healthspan landscape.